Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

AKLI

Akili Inc

Last Close
May 16 • 04:00PM ET
0.4321
Dollar change
-0.0006
Percentage change
-0.14 		%
Held by: IWC VXF VTI Scroll to Statements
Index- P/E- EPS (ttm)-0.61 Insider Own32.81% Shs Outstand78.36M Perf Week-2.77%
Market Cap33.96M Forward P/E- EPS next Y-0.46 Insider Trans0.00% Shs Float52.81M Perf Month102.67%
Income-48.55M PEG- EPS next Q-0.13 Inst Own36.71% Short Float0.22% Perf Quarter88.69%
Sales1.95M P/S17.42 EPS this Y27.14% Inst Trans19.71% Short Ratio0.03 Perf Half Y4.12%
Book/sh0.75 P/B0.58 EPS next Y9.80% ROA-50.58% Short Interest0.11M Perf Year-69.57%
Cash/sh0.81 P/C0.54 EPS next 5Y- ROE-68.06% 52W Range0.19 - 1.67 Perf YTD-11.29%
Dividend Est.- P/FCF- EPS past 5Y- ROI-87.43% 52W High-74.13% Beta1.73
Dividend TTM- Quick Ratio6.02 Sales past 5Y209.75% Gross Margin67.66% 52W Low125.99% ATR (14)0.04
Dividend Ex-Date- Current Ratio5.80 EPS Y/Y TTM-154.71% Oper. Margin-2886.60% RSI (14)66.31 Volatility5.30% 10.18%
Employees- Debt/Eq0.27 Sales Y/Y TTM- Profit Margin-2492.04% Recom2.00 Target Price0.65
Option/ShortYes / Yes LT Debt/Eq0.11 EPS Q/Q55.15% Payout- Rel Volume0.03 Prev Close0.43
Sales Surprise-52.12% EPS Surprise0.00% Sales Q/Q238.94% EarningsMay 14 AMC Avg Volume3.93M Price0.43
SMA2024.59% SMA5042.17% SMA200-11.41% Trades Volume102,488 Change-0.14%
Date Action Analyst Rating Change Price Target Change
Nov-18-22Initiated BofA Securities Neutral $2
Oct-25-22Initiated Credit Suisse Outperform $5
Sep-06-22Initiated Cowen Outperform
May-14-24 08:56PM
AKLI Stock Earnings: Akili Beats EPS, Misses Revenue for Q1 2024
(InvestorPlace)
04:01PM
Akili Reports First Quarter 2024 Financial Results and Provides Business Update
(Business Wire)
Apr-30-24 12:45PM
AGBA Stock Pops 35% on Triller Merger Update
(InvestorPlace) +70.29%
12:28PM
Why Is Akili (AKLI) Stock Up 68% Today?
(InvestorPlace)
08:00AM
Akili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial Results
(Business Wire)
04:01PM Loading…
Feb-29-24 04:01PM
Akili Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
(Business Wire) -7.81%
Feb-27-24 02:00AM
PureTech Founded Entity Akili Announces Positive Results from Shionogis Phase 3 Clinical Trial of Localized Version of Akilis EndeavorRx for Pediatric ADHD Patients in Japan
(Business Wire)
Feb-26-24 01:51PM
Why Is Akili (AKLI) Stock Up 110% Today?
(InvestorPlace) +104.11%
08:47AM
Akili Announces Positive Results from Shionogis Phase 3 Clinical Trial of Localized Version of Akilis EndeavorRx for Pediatric ADHD Patients in Japan
(Business Wire)
Feb-21-24 04:05PM
Akili Announces Release Date for Fourth Quarter and Full Year 2023 Financial Results, Provides Investor Communications and Board and Corporate Governance Updates
(Business Wire) -10.59%
Jan-15-24 09:55AM
Akili, Inc. (AKLI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
(Zacks)
Dec-29-23 08:22AM
Chamath Palihapitiya Stocks: 12 Stocks Pumped in the Last 10 Years
(Insider Monkey)
Dec-21-23 12:00PM
Akili, Inc. (AKLI) Upgraded to Buy: Here's What You Should Know
(Zacks)
Dec-18-23 08:00AM
EndeavorRx, Worlds First and Only Prescription Video Game Treatment, Secures FDA Label Expansion for Pediatric ADHD Patients Aged 13-17
(Business Wire) +16.23%
Nov-13-23 09:36AM
Akili, Inc. (NASDAQ:AKLI) Q3 2023 Earnings Call Transcript
(Insider Monkey)
04:02PM Loading…
Nov-09-23 04:02PM
Akili Reports Third Quarter 2023 Financial Results and Provides Business Update
(Business Wire)
Oct-19-23 12:27PM
Akili to Host Third Quarter Financial Results Conference Call and Webcast on Thursday, November 9 at 4:30 p.m. ET
(Business Wire) -8.24%
Oct-12-23 08:00AM
Employees with ADHD Arent Reaching Their Full Potential at Work, Akili Study Finds
(Business Wire)
Oct-06-23 07:00AM
Akili Announces Leadership Transition
(Business Wire)
Sep-21-23 08:00AM
Akili Releases EndeavorOTC on Android Devices, Expanding Treatment Access for Millions of Adults with ADHD
(Business Wire) -16.06%
Sep-15-23 03:03AM
Insider Sell: CEO Martucci Walter Edward II Sells 2,353 Shares of Akili Inc
(GuruFocus.com) -28.66%
Sep-13-23 01:16PM
Digital health startup Akili cuts staff by 40%, abandons prescription model
(American City Business Journals)
08:00AM
Akili Announces Business Transformation, Focusing on Non-prescription Model
(Business Wire)
Aug-14-23 09:26AM
Akili, Inc. (NASDAQ:AKLI) Q2 2023 Earnings Call Transcript
(Insider Monkey)
Aug-11-23 06:43AM
Q2 2023 Akili Inc Earnings Call
(Thomson Reuters StreetEvents)
Aug-10-23 04:01PM
Akili Reports Second Quarter 2023 Financial Results and Provides Business Update
(Business Wire)
Jul-10-23 07:00AM
Akili to Host Second Quarter Financial Results Conference Call and Webcast on Thursday, August 10 at 4:30 p.m. ET
(Business Wire)
Jun-08-23 01:20PM
EndeavorOTC Elevates ADHD Treatment: Unprecedented Mobile Game Therapy for Adults
(Benzinga)
Jun-07-23 07:00AM
Akili Releases EndeavorOTCTM Video Game Treatment to Improve Attention in Adults with ADHD
(Business Wire)
May-31-23 07:00AM
Akili to Present Clinical Data from Pivotal Trial of Video Game Treatment in Adolescents with ADHD at 2023 ASCP Annual Meeting and Elevate Psych Congress
(Business Wire)
11:12AM Loading…
May-12-23 11:12AM
Q1 2023 Akili Inc Earnings Call
(Thomson Reuters StreetEvents) +11.90%
May-11-23 04:01PM
Akili Reports First Quarter 2023 Financial Results and Provides Business Update
(Business Wire)
May-04-23 02:00AM
PureTech Founded Entity Akili Announces Adults with ADHD See Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akilis EndeavorRx® Video Game-Based Therapeutic
(Business Wire) -6.88%
May-03-23 04:56PM
Game-Changing ADHD Treatment: Akili's EndeavorRx Shows Significant Improvement in Adult Attention Functioning
(Benzinga) +46.79%
07:00AM
Adults with ADHD See Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akilis EndeavorRx® Video Game-Based Therapeutic
(Business Wire)
Apr-13-23 08:00AM
Akili to Host First Quarter Financial Results Conference Call and Webcast on Thursday, May 11 at 4:30 p.m. ET
(Business Wire)
Mar-13-23 11:51AM
Akili, Inc. (NASDAQ:AKLI) Q4 2022 Earnings Call Transcript
(Insider Monkey) -8.97%
Mar-08-23 08:32AM
Q4 2022 Akili Inc Earnings Call
(Thomson Reuters StreetEvents)
Mar-07-23 04:01PM
Akili Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
(Business Wire) -5.38%
Feb-08-23 11:37AM
Akili, Inc.'s (NASDAQ:AKLI) market cap up US$26m last week, benefiting both individual investors who own 26% as well as insiders
(Simply Wall St.) +14.74%
Feb-06-23 07:00AM
Akili to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on Tuesday, March 7 at 4:30 p.m. ET
(Business Wire)
Feb-02-23 07:00AM
Akili to Participate in the Cowen 43rd Annual Health Care Conference
(Business Wire)
Jan-06-23 10:43AM
Akili to Champion Digital Therapeutics in Conjunction with J.P. Morgan Healthcare Conference
(Business Wire) -14.07%
Jan-05-23 07:00AM
Pivotal Trial of EndeavorRx in Adolescents with ADHD Shows Robust Improvements in Attention and Broader Clinical Outcomes
(Business Wire) +25.00%
Dec-29-22 02:44PM
Morgan Stanley Initiates Coverage On This Digital Therapeutics Stock With Attractive View
(Benzinga) +5.97%
Dec-27-22 11:05AM
Chamath Palihapitiya Stocks: 10 Stocks Picked in the Last 10 Years
(Insider Monkey) -13.79%
Dec-01-22 07:00AM
Akili Announces ADHD Expert Dr. Scott Kollins to Join as Chief Medical Officer
(Business Wire) +10.96%
Nov-19-22 07:52AM
Akili Third Quarter 2022 Earnings: EPS: US$1.38 (vs US$16.67 loss in 3Q 2021)
(Simply Wall St.)
Nov-10-22 04:01PM
Akili Reports Third Quarter 2022 Financial Results and Company Update
(Business Wire)
Nov-01-22 11:53AM
Down More Than 50%: These 3 Strong Buy Stocks Are Too Cheap to Ignore
(TipRanks) +5.45%
Oct-27-22 07:00AM
Financial Industry Veteran Mary Hentges Joins Akilis Board of Directors
(Business Wire) -5.29%
Oct-19-22 07:00AM
Akili to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Thursday, November 10 at 4:30 p.m. ET
(Business Wire)
Sep-21-22 07:00AM
Akili Launches EndeavorRx® Expedition - A Direct-to-Patient Product Registry
(Business Wire) -9.84%
Sep-19-22 07:00AM
Akili to Participate in LifeSci Partners HealthTech Symposium
(Business Wire) -14.03%
Aug-22-22 04:08PM
Akili 'took the last decade to clinically validate' its video game treatment for ADHD: CEO
(Yahoo Finance Video) -49.18%
Akili, Inc. is a digital medicine company, which engages in the development of cognitive treatments through technologies. Its technologies are designed to directly target the physiology of the brain. The company was founded by W. Edward Martucci II and Adam Gazzaley in December 2020 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Martucci Walter Edward IIChief Executive OfficerSep 11 '23Sale1.052,3532,4713,150,180Sep 14 08:30 AM
Franklin MatthewPresident & COOSep 11 '23Sale1.051,7281,814753,898Sep 14 08:29 AM
Studer JacquelineChief Legal OfficerSep 11 '23Sale1.051,1301,186348,292Sep 14 08:31 AM
Shanbhag SantoshChief Financial OfficerSep 11 '23Sale1.05830872323,636Sep 14 08:28 AM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.